Sign in

CIK 0001750149 · Non-accelerated filer<br>Smaller reporting company

Inhibikase Therapeutics, Inc.

Sign in to watch
Ticker
IKT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
263407249
Phone
(302) 295-3800
Business address
1000 N. WEST STREET, SUITE 1200, WILMINGTON, DE, 19801
  1. 4 Insider Changes in Ownership
  2. 8-K Event Shareholder vote results
  3. SC 13D Stake Beneficial Ownership Report
  4. 8-K Event Regulation FD disclosure
  5. 424B4 Offering Prospectus
  6. 8-K Event Material agreement
  7. EFFECT Other Notice of Effectiveness
  8. CORRESP Other Correspondence Between Filers and SEC Staff
  9. CORRESP Other Correspondence Between Filers and SEC Staff
  10. S-1 Offering Registration Statement
  11. UPLOAD Other SEC-generated Letter
  12. DRS Other Draft Registration Statement
  13. 8-K Event Regulation FD disclosure
  14. 4 Insider Changes in Ownership
  15. 10-Q Report Quarterly Report
  16. DEFA14A Proxy Proxy Materials
  17. DEF 14A Proxy Proxy Statement
  18. 8-K Event Results of operations
  19. 10-K Report Annual Report
  20. SC 13G Stake Amended Statement of Ownership

Page 16 of 19 · 370 filings